Increased expression of glutaminase and glutamine synthetase mRNA in the thalamus in schizophrenia
- PMID: 15820321
- DOI: 10.1016/j.schres.2004.12.012
Increased expression of glutaminase and glutamine synthetase mRNA in the thalamus in schizophrenia
Abstract
Numerous molecules enable the handling of glutamate that is destined for neurotransmitter release, including transporters, receptors and glutamatergic enzymes. Previous work in our lab has shown altered levels of transcript expression of excitatory amino acid transporters and a vesicular glutamate transporter in the thalamus in schizophrenia. These changes suggest that molecules that facilitate the release and reuptake of glutamate may be abnormal in schizophrenia. In this study we determined the levels of expression of phosphate activated glutaminase (PAG), which converts glutamine to glutamate, and glutamine synthetase (GS), which converts glutamate to glutamine, with the hypothesis that thalamic PAG and GS transcript expression is altered in schizophrenia. We investigated expression of PAG and GS mRNA using in situ hybridization in six different thalamic nuclei (anterior, dorsomedial, centromedial, ventral anterior, ventral and reticular) from 13 persons with schizophrenia and 8 comparison subjects and found that transcripts for PAG and GS were significantly increased in schizophrenia. Increased PAG and GS transcripts suggest enhanced glutamatergic neurotransmission in the thalamus and its efferent _targets in schizophrenia.
Similar articles
-
Expression of excitatory amino acid transporter interacting protein transcripts in the thalamus in schizophrenia.Synapse. 2006 Jun 1;59(7):394-402. doi: 10.1002/syn.20250. Synapse. 2006. PMID: 16485262
-
Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia.Am J Psychiatry. 2001 Sep;158(9):1393-9. doi: 10.1176/appi.ajp.158.9.1393. Am J Psychiatry. 2001. PMID: 11532723
-
Mechanisms governing the expression of the enzymes of glutamine metabolism--glutaminase and glutamine synthetase.J Nutr. 2001 Sep;131(9 Suppl):2467S-74S; discussion 2486S-7S. doi: 10.1093/jn/131.9.2467S. J Nutr. 2001. PMID: 11533295
-
Molecular abnormalities of the glutamate synapse in the thalamus in schizophrenia.Ann N Y Acad Sci. 2003 Nov;1003:75-93. doi: 10.1196/annals.1300.005. Ann N Y Acad Sci. 2003. PMID: 14684436 Review.
-
Disruption of glutamate-glutamine-GABA cycle significantly impacts on suicidal behaviour: survey of the literature and own findings on glutamine synthetase.CNS Neurol Disord Drug _targets. 2013 Nov;12(7):900-13. doi: 10.2174/18715273113129990091. CNS Neurol Disord Drug _targets. 2013. PMID: 24040807 Review.
Cited by
-
Synaptic underpinnings of altered hippocampal function in glutaminase-deficient mice during maturation.Hippocampus. 2012 May;22(5):1027-39. doi: 10.1002/hipo.22014. Epub 2012 Mar 19. Hippocampus. 2012. PMID: 22431402 Free PMC article.
-
Glutamatergic abnormalities of the thalamus in schizophrenia: a systematic review.J Neural Transm (Vienna). 2008;115(3):493-511. doi: 10.1007/s00702-007-0859-5. Epub 2008 Feb 26. J Neural Transm (Vienna). 2008. PMID: 18301955 Review.
-
Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia.Schizophr Res. 2008 Aug;103(1-3):71-82. doi: 10.1016/j.schres.2008.04.032. Epub 2008 Jun 17. Schizophr Res. 2008. PMID: 18562176 Free PMC article.
-
_target identification for CNS diseases by transcriptional profiling.Neuropsychopharmacology. 2009 Jan;34(1):18-54. doi: 10.1038/npp.2008.172. Epub 2008 Oct 15. Neuropsychopharmacology. 2009. PMID: 18923405 Free PMC article. Review.
-
Regional decoupling of N-acetyl-aspartate and glutamate in schizophrenia.Neuropsychopharmacology. 2012 Nov;37(12):2635-42. doi: 10.1038/npp.2012.126. Epub 2012 Jul 18. Neuropsychopharmacology. 2012. PMID: 22805603 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
